ATLANTA – The lawyer representing talc powder plaintiffs has responded to Johnson & Johnson’s request to disqualify him from the case, calling it a “smear tactic.” The plaintiff lawyer, Mark Lanier from Texas, rejected the bid and denounced the company’s attempt to discredit him.
Johnson & Johnson, one of the world’s largest pharmaceutical companies, sought to remove Lanier from the lawsuit filed by individuals who claim the company’s talc-based products caused cancer. In their motion, Johnson & Johnson accused Lanier of breaching client confidentiality. However, Lanier strongly refuted these allegations, stating that he has adhered to ethical and professional standards throughout the case.
Lanier argued that Johnson & Johnson’s move to disqualify him was a strategic ploy to undermine his credibility and that of his clients. He accused the company of resorting to “smear tactics” rather than addressing the substantive issues raised in the lawsuit. The lawyer’s response highlighted the desperation of the pharmaceutical giant to avoid accountability for its alleged negligence.
The talc litigation against Johnson & Johnson has been a long-standing battle, with numerous lawsuits filed by consumers alleging that the company’s talc-based products contain asbestos and have caused ovarian cancer and mesothelioma. Johnson & Johnson denies these claims and maintains that its products are safe. The company has faced significant legal setbacks in previous cases, including multi-million dollar verdicts in favor of the plaintiffs.
By seeking to disqualify Lanier, Johnson & Johnson is aiming to disrupt the plaintiffs’ legal team and weaken their case. However, Lanier remains steadfast in his position and continues to advocate for his clients’ rights. His response to Johnson & Johnson’s request reflects his determination to fight for justice and hold the company accountable for any wrongdoing.
In conclusion, talc powder plaintiffs’ lawyer Mark Lanier has rebuffed Johnson & Johnson’s attempt to disqualify him from the case, labeling it a “smear tactic.” The legal battle against the pharmaceutical giant continues as plaintiffs seek justice for alleged health issues caused by the company’s talc-based products.